» Articles » PMID: 9712920

Activated Raf Induces the Hyperphosphorylation of Stathmin and the Reorganization of the Microtubule Network

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1998 Aug 26
PMID 9712920
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Raf kinases are regulators of cellular proliferation, transformation, differentiation, and apoptosis. To identify downstream targets of Raf-1 in vivo, we used NIH 3T3 fibroblasts expressing a Raf-1 kinase domain-estrogen receptor fusion protein (BXB-ER), whose activity can be acutely regulated by estrogen. Proteins differentially phosphorylated 20 min after BXB-ER activation in living cells were displayed by two-dimensional electrophoresis. The protein with the most prominent newly induced phosphorylation was identified as stathmin, a phosphorylation-sensitive regulator of microtubule dynamics. Stathmin is rapidly phosphorylated on two ERK phosphorylation sites (serines 25 and 38) upon BXB-ER activation. The mitogen-activated protein kinase/extracellular signal-regulated kinase-kinase (MEK) inhibitor PD98059 abolished this phosphorylation, demonstrating that stathmin is targeted by BXB-ER via the MEK/ERK pathway. Prolonged BXB-ER activation resulted in the accumulation of a stathmin phosphoisomer with impaired microtubule-destabilizing activity. The appearance of this phosphoisomer after BXB-ER activation correlated with rearrangements in the microtubule network, resulting in the formation of long bundled microtubules extending toward the rim of the cells. Our results identify stathmin as a main target of the Raf/MEK/ERK kinase cascade in vivo and strongly suggest that ERK-mediated stathmin phosphorylation plays an important role for the microtubule reorganization induced by acute activation of Raf-1.

Citing Articles

The Marine Natural Product Furospinulosin 1 Induces Apoptosis in MDA-MB-231 Triple Negative Breast Cancer Cell Spheroids, But Not in Cells Grown Traditionally with Longer Treatment.

Guzman E, Pitts T, Winder P, Wright A Mar Drugs. 2021; 19(5).

PMID: 33924764 PMC: 8145321. DOI: 10.3390/md19050249.


MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma.

Jain A, Patel K, Pinto S, Radhakrishnan A, Nanjappa V, Kumar M Sci Rep. 2019; 9(1):18793.

PMID: 31827134 PMC: 6906491. DOI: 10.1038/s41598-019-55208-5.


Global view of the RAF-MEK-ERK module and its immediate downstream effectors.

Santini C, Longden J, Schoof E, Simpson C, Jeschke G, Creixell P Sci Rep. 2019; 9(1):10865.

PMID: 31350469 PMC: 6659682. DOI: 10.1038/s41598-019-47245-x.


Stathmin mediates hepatocyte resistance to death from oxidative stress by down regulating JNK.

Zhao E, Amir M, Lin Y, Czaja M PLoS One. 2014; 9(10):e109750.

PMID: 25285524 PMC: 4186850. DOI: 10.1371/journal.pone.0109750.


Serine-threonine kinases in TCR signaling.

Navarro M, Cantrell D Nat Immunol. 2014; 15(9):808-14.

PMID: 25137455 PMC: 6443032. DOI: 10.1038/ni.2941.